EPHB1/EPHB2/EPHB3/EPHB4 (Ab-600/602/614/596) Antibody

What are EphB receptors and what biological processes do they regulate?

EphB receptors belong to the largest subgroup of the receptor tyrosine kinase (RTK) family. They interact with ephrin-B ligands to mediate numerous developmental processes, particularly in the nervous system. EphB receptors are divided into groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin ligands .

The EphB family includes EphB1, EphB2, EphB3, EphB4, and EphB6, with the first four possessing catalytically active kinase domains. These receptors regulate critical cellular processes including:

• Cell adhesion and migration

• Cellular repulsion and segregation control

• Vascular development

• Neural development and axon guidance

• Tissue boundary formation

EphB activation occurs through interaction with ephrin-B ligands, particularly ephrin-B2, which triggers receptor clustering, phosphorylation, and kinase activation, followed by downstream signaling cascades .

What is the significance of tyrosine phosphorylation at positions 600/602/614/596 in EPHB1/2/3/4 receptors?

Tyrosine phosphorylation at positions Tyr600 (EPHB1), Tyr602 (EPHB2), Tyr614 (EPHB3), and Tyr596 (EPHB4) represents a crucial step in the activation mechanism of these receptors. These phosphorylation sites are located in the juxtamembrane region of EphB receptors and are essential for:

• Receptor activation and signaling: Phosphorylation at these sites indicates active receptor signaling after ephrin-B binding

• Downstream effector recruitment: Phosphorylated tyrosine residues create docking sites for SH2 domain-containing proteins

• Activation of downstream signaling pathways: Including Src family kinases, which can be recruited to activated EphB receptors

The antibody that specifically recognizes these phosphorylated residues serves as a direct readout for receptor kinase activation, allowing researchers to monitor EphB receptor activity in various experimental contexts .

How do EphB receptors differ structurally and functionally from EphA receptors?

EphB and EphA receptors differ in several key aspects:

Despite these differences, both receptor families share the same general domain structure: an extracellular ligand-binding domain, a transmembrane segment, and an intracellular region containing the tyrosine kinase domain. The high sequence and structural identity within the EphB family (particularly in their kinase domains) presents challenges for developing selective therapeutic molecules .

How should I design experiments to validate the specificity of the EPHB1/2/3/4 (Ab-600/602/614/596) antibody?

Validating antibody specificity is critical for obtaining reliable research results. For the Phospho-EphB1/EphB2/EphB3/EphB4 antibody, implement the following comprehensive validation strategy:

• Positive controls:

  • Use cell lines with known expression of EphB receptors (e.g., HEK293 transfected with EphB2, HeLa, NCI-H460, Saos-2, SK-Mel-28, and U2OS)

  • Stimulate cells with ephrin-B1 ligand to induce phosphorylation

• Negative controls:

  • Use knockout (KO) cell lines for each EphB receptor

  • Employ kinase-dead EphB mutants (e.g., EphB2K662R)

  • Treat with phosphatase to remove phosphorylation

  • Use PP1 analogs in AS-EphB (analog-sensitive) expressing cells

• Specificity tests:

  • Perform peptide competition assays with phosphorylated and non-phosphorylated peptides

  • Use antibody in cells before and after ephrin-B1 stimulation to demonstrate inducible phosphorylation

• Cross-reactivity assessment:

  • Test against related RTK family members

  • Validate across multiple applications (Western blot, immunoprecipitation, immunofluorescence)

According to recent studies on antibody characterization, using KO cell lines provides superior validation compared to other control methods, particularly for Western blots and immunofluorescence imaging .

What are the best experimental techniques to study EphB receptor activation and signaling using the phospho-specific antibody?

Several techniques are particularly valuable when using phospho-specific EphB antibodies:

• Western Blotting:

  • Most common application for detecting receptor activation

  • Can visualize both total and phosphorylated receptor pools

  • Protocol: Stimulate cells with clustered ephrin-B1 for 30 minutes, lyse cells, separate by SDS-PAGE, and probe with phospho-EphB antibody

• Immunoprecipitation followed by Western blotting:

  • Allows enrichment of low-abundance receptors

  • Can be used to study protein-protein interactions

  • Useful for analyzing specific EphB family members in complex samples

• Immunofluorescence:

  • Visualizes receptor localization and activation in situ

  • Can reveal spatial patterns of receptor activation

• Pharmacological manipulation:

  • Use specific inhibitors (e.g., PP1 analogs in AS-EphB systems)

  • Compare effects of kinase-dead mutants

  • Protocol: Pre-incubate cultured neurons with vehicle or PP1 analogs (250 nM 1-NA-PP1 or 1 μM 3-MB-PP1) for 1 hour before ephrin-B1 stimulation

• Time-course studies:

  • Monitor dynamics of receptor activation following ephrin stimulation

  • Typically examine time points from 5 minutes to 24 hours post-stimulation

Each technique provides complementary information about receptor activation and downstream signaling events .

How can I quantify EphB receptor activation in cells and tissues?

Accurate quantification of EphB receptor activation is essential for comparative studies. Consider these methodological approaches:

• Western blot quantification:

  • Normalize phospho-EphB signal to total EphB protein levels

  • Use digital imaging and analysis software (e.g., ImageJ)

  • Compare to a standard curve of known phosphorylated protein amounts

  • Include loading controls (e.g., β-actin, GAPDH)

• Flow cytometry:

  • Enables single-cell analysis of receptor activation

  • Can be used with live cells to monitor activation dynamics

  • Protocol: Fix and permeabilize cells, stain with phospho-EphB antibody followed by fluorescently-labeled secondary antibody

• Quantitative immunofluorescence:

  • Measure fluorescence intensity using confocal microscopy

  • Calculate the ratio of phospho-EphB to total EphB signal

  • Useful for spatial analysis of activation in tissues

• ELISA/AlphaLISA:

  • Develop sandwich assays using capture antibodies against total EphB and detection with phospho-specific antibody

  • Provides highly quantitative data suitable for high-throughput screening

• Mass spectrometry:

  • For absolute quantification of phosphorylation stoichiometry

  • Can identify all phosphorylation sites simultaneously

When reporting results, include both raw and normalized data, statistical analyses, and clear descriptions of quantification methods .

How can I use the phospho-EphB antibody to investigate cross-talk between EphB and other signaling pathways?

Investigating signaling cross-talk requires sophisticated experimental approaches:

• Co-immunoprecipitation studies:

  • Use phospho-EphB antibody to pull down activated receptors

  • Identify co-precipitating proteins by Western blotting or mass spectrometry

  • Example: Co-immunoprecipitation of L1 cell adhesion molecule with EphB2 reveals direct or indirect molecular association

• Proximity ligation assays:

  • Detect protein-protein interactions in situ

  • Can visualize interactions between phosphorylated EphB and potential partners

• Pathway inhibitor studies:

  • Combine EphB activation with inhibitors of related pathways

  • Example: PP2 (Src family kinase inhibitor) completely inhibits phosphorylation of L1 at FIGQY by EphB2, suggesting Src kinases function as downstream effectors of EphB2

• Phosphoproteomic analysis:

  • Global analysis of phosphorylation changes following EphB activation

  • Identify novel downstream targets and pathway connections

• Genetic approaches:

  • Use CRISPR/Cas9 to knockout components of related pathways

  • Examine effects on EphB phosphorylation and signaling

A specific example from the research literature demonstrates that EphB2 mediates tyrosine phosphorylation of L1 cell adhesion molecule at the FIGQY motif, which regulates L1-ankyrin binding and is important for retinocollicular mapping of retinal ganglion cell axons. This cross-talk mechanism involves Src family kinases as downstream effectors of EphB2 kinase .

What are the challenges in studying specific EphB receptor subtypes using phospho-specific antibodies?

Studying individual EphB receptor subtypes presents several challenges:

• High sequence homology:

  • The tyrosine residues targeted by the phospho-specific antibody (Tyr600/602/614/596) reside in highly conserved regions

  • 75-95% sequence identity in kinase domains makes selective detection difficult

• Co-expression of multiple EphB receptors:

  • Many cell types express multiple EphB receptors simultaneously

  • Difficult to attribute phospho-specific signals to individual subtypes

• Cross-reactivity concerns:

  • Phospho-specific antibodies may recognize multiple EphB family members

  • Need for careful validation in each experimental system

• Solution strategies:

  • Combine with subtype-specific total EphB antibodies

  • Use knockdown/knockout approaches for individual receptors

  • Employ analog-sensitive (AS) EphB mutants for selective inhibition

  • Example: EphB1T697G, EphB2T699A, and EphB3T706A mutants that are selectively inhibited by PP1 analogs

• Novel approaches:

  • Single-cell analysis techniques

  • Selective agonists/antagonists like UniPR1447 (K_i values: 1.4 μM for EphA2 and 2.6 μM for EphB2)

  • Structure-guided design of isozyme-selective inhibitors based on X-ray crystallography data of EphB kinase domains

Understanding the structural differences between EphB family members, as revealed by crystallography studies, provides opportunities to develop more selective tools for studying individual EphB receptors .

How can I use phospho-EphB antibodies to study the role of EphB signaling in disease models?

EphB receptors have been implicated in various diseases, including cancer and neurodevelopmental disorders. To investigate their role:

• Cancer research applications:

  • Compare phospho-EphB levels between normal and tumor tissues

  • Correlate with clinical outcomes and prognostic markers

  • Examine effects of EphB-targeting compounds on receptor activation

  • Example: Aberrant DNA methylation and epigenetic inactivation of Eph receptors in acute lymphoblastic leukemia suggest tumor suppressor functions

• Neurodevelopmental disorder models:

  • Analyze phospho-EphB patterns during critical developmental windows

  • Study effects of disease-associated mutations on receptor activation

  • Example: EphB signaling is essential for retinocollicular mapping of retinal ganglion cell axons

• In vivo applications:

  • Immunohistochemistry of tissue sections

  • Analysis of primary cells isolated from disease models

  • Pharmacological intervention studies with EphB antagonists

• Therapeutic development:

  • Screen compounds for effects on EphB phosphorylation

  • Evaluate specificity across EphB family members

  • Monitor target engagement in preclinical models

• Translational research:

  • Develop phospho-EphB analysis as potential biomarkers

  • Assess receptor activation in patient samples

  • Correlate with response to targeted therapies

The conflicting expression patterns of EphB receptors in cancer tissues present interesting challenges to those seeking to develop selective therapeutic molecules. Understanding the specific activation patterns using phospho-specific antibodies can help clarify which receptors to target in different disease contexts .

What are common technical pitfalls when using phospho-EphB antibodies and how can they be avoided?

Several technical challenges can affect experiments with phospho-EphB antibodies:

• Phosphatase activity during sample preparation:

  • Problem: Rapid loss of phosphorylation signals during cell lysis

  • Solution: Include phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate) in all buffers; maintain samples at 4°C; use rapid sample processing

• Antibody specificity issues:

  • Problem: Cross-reactivity with other phosphorylated RTKs

  • Solution: Include proper controls (knockout cells, dephosphorylated samples); validate with multiple techniques; use peptide competition

• Signal-to-noise ratio:

  • Problem: Weak phosphorylation signals, especially with endogenous expression levels

  • Solution: Optimize stimulation conditions; use signal enhancement methods; enrich targets by immunoprecipitation before Western blotting

• Reproducibility challenges:

  • Problem: Variation in phosphorylation levels between experiments

  • Solution: Standardize stimulation protocols; use internal controls; carefully control cell density and growth conditions; quantify results across multiple experiments

• Antibody batch variation:

  • Problem: Performance differences between antibody lots

  • Solution: Test each new lot against a reference standard; maintain a stock of validated antibody for critical experiments

The recent focus on antibody characterization crisis highlights that approximately 50% of commercial antibodies fail to meet basic standards for characterization. Using knockout cell lines and multiple validation approaches is essential for reliable results .

How do I troubleshoot weak or absent phospho-EphB signals in my experiments?

When facing weak or absent phospho-EphB signals, consider this systematic troubleshooting approach:

• Verify EphB expression:

  • Confirm receptor expression using antibodies against total EphB

  • Check mRNA levels by qPCR if protein detection is challenging

  • Example: qPCR can verify that EphB mRNAs are expressed at expected levels

• Optimize stimulation conditions:

  • Test different concentrations of ephrin ligands (typically 1-5 μg/mL)

  • Use pre-clustered ephrins for more potent activation

  • Optimize stimulation time (typically 15-30 minutes for peak phosphorylation)

  • Example protocol: Stimulate with clustered ephrin-B1 for 30 minutes

• Improve sample preparation:

  • Ensure complete cell lysis (use stronger detergents if needed)

  • Add fresh phosphatase inhibitors to all buffers

  • Process samples quickly and keep cold

  • Consider enriching by immunoprecipitation before Western blotting

• Enhance detection sensitivity:

  • Use high-sensitivity ECL substrates for Western blotting

  • Optimize antibody concentrations and incubation conditions

  • Try signal amplification systems

• Check for technical issues:

  • Verify transfer efficiency in Western blotting

  • Ensure antibody is stored properly and not degraded

  • Test positive control samples (e.g., HEK293 cells transfected with EphB2)

If signals remain weak, consider that your experimental system may have low baseline phosphorylation or regulatory mechanisms suppressing EphB activation .

What are the best practices for quantifying and statistically analyzing phospho-EphB signals?

• Western blot quantification:

  • Ensure linear range of detection (run dilution series)

  • Use digital imaging rather than film exposure

  • Normalize phospho-signal to total protein levels

  • Include technical replicates on each blot

  • Analyze using software like ImageJ with consistent processing parameters

• Experimental design considerations:

  • Perform at least three biological replicates

  • Include appropriate controls in each experiment

  • Use randomization and blinding where possible

  • Consider power analysis to determine sample size

• Data normalization approaches:

  • Calculate phospho/total protein ratios

  • Normalize to unstimulated control samples

  • Consider fold-change relative to baseline

• Statistical analysis methods:

  • For comparing two conditions: paired t-test or Wilcoxon signed-rank test

  • For multiple conditions: ANOVA with appropriate post-hoc tests

  • For non-normally distributed data: non-parametric tests

  • Report exact p-values rather than thresholds

• Data presentation:

  • Show representative blot images alongside quantification

  • Include error bars representing standard deviation or SEM

  • Present individual data points along with means/medians

  • Clearly describe all statistical methods in figure legends

Studies have shown that proper normalization and statistical analysis are critical for reproducible results when using phospho-specific antibodies .

How can phospho-EphB antibodies be used in conjunction with advanced imaging techniques?

Combining phospho-EphB antibodies with cutting-edge imaging approaches opens new research possibilities:

• Super-resolution microscopy:

  • Techniques: STORM, PALM, or STED microscopy

  • Applications: Visualize nanoscale clustering of phosphorylated EphB receptors

  • Advantages: Resolves receptor distribution below diffraction limit

  • Protocol considerations: Requires highly specific antibodies and appropriate fluorophores

• Live-cell imaging:

  • Techniques: FRET-based biosensors for EphB activation

  • Applications: Monitor real-time dynamics of receptor phosphorylation

  • Advantages: Captures temporal patterns of activation

  • Example approach: Develop phospho-specific FRET reporters based on antibody epitopes

• Multiplexed imaging:

  • Techniques: Cyclic immunofluorescence, mass cytometry imaging

  • Applications: Simultaneously visualize multiple phosphorylated signaling proteins

  • Advantages: Reveals relationships between different signaling pathways

  • Technical considerations: Requires careful antibody validation and signal separation

• Tissue clearing and 3D imaging:

  • Techniques: CLARITY, iDISCO, or CUBIC clearing methods

  • Applications: Map phospho-EphB distribution throughout intact tissues

  • Advantages: Maintains spatial context and tissue architecture

  • Protocol considerations: Optimization for antibody penetration in cleared tissues

• Correlative light and electron microscopy:

  • Applications: Connect phospho-EphB localization with ultrastructural features

  • Advantages: Links molecular signaling to cellular structures

  • Technical considerations: Requires specialized sample preparation

These advanced imaging approaches can reveal spatial relationships between phosphorylated EphB receptors and their effectors that are not apparent with conventional techniques .

What are the latest developments in using phospho-EphB antibodies for diagnostic or therapeutic applications?

Recent research reveals several emerging applications:

• Diagnostic biomarker development:

  • Phospho-EphB levels as indicators of pathway activation in tumors

  • Potential prognostic value in cancer subtypes

  • Technical considerations: Development of clinical-grade assays with validated antibodies

  • Challenges: Standardization across clinical laboratories

• Precision medicine applications:

  • Guiding therapy selection based on receptor activation status

  • Monitoring treatment response through phosphorylation changes

  • Example approach: Development of companion diagnostics for EphB-targeted therapies

• Drug discovery applications:

  • High-throughput screening for compounds affecting EphB phosphorylation

  • Target engagement biomarkers in preclinical and clinical studies

  • Technical considerations: Adaptation of phospho-antibodies to HTS formats

• Therapeutic antibodies:

  • Development of function-modulating antibodies targeting EphB receptors

  • Phospho-specific antibodies as templates for therapeutic development

  • Challenges: Achieving specificity among family members

• Theranostic approaches:

  • Combined diagnostic and therapeutic applications

  • Example: Labeled antibodies for both imaging and targeted therapy

  • Technical considerations: Modification of antibodies for dual functionality

The differential expression patterns of EphB receptors in cancer tissues suggest potential for targeted therapeutic approaches, though their high sequence homology presents challenges for developing selective agents .

How might phospho-EphB antibodies contribute to our understanding of receptor cross-activation and transphosphorylation mechanisms?

Phospho-specific antibodies offer unique insights into complex receptor activation mechanisms:

• Auto- versus trans-phosphorylation:

  • Using phospho-EphB antibodies to distinguish between these mechanisms

  • Experimental approach: Co-express wild-type and kinase-dead receptors

  • Analysis method: Immunoprecipitate specific receptor forms and probe for phosphorylation

  • Insight from research: Partial ordering of the activation loop in the EphB3 structure suggests a potential cis-phosphorylation mechanism for EphB kinases

• Receptor clustering dynamics:

  • Monitoring phosphorylation patterns during receptor clustering

  • Approach: Time-course analysis following ephrin stimulation

  • Technical considerations: Combining with proximity-based assays (BiFC, PLA)

  • Example finding: Clustering is required for efficient receptor phosphorylation

• Heterotypic receptor interactions:

  • Investigating cross-activation between different EphB subtypes

  • Experimental design: Co-express different receptor subtypes and selectively activate one

  • Analysis method: Use subtype-specific total antibodies with phospho-specific detection

  • Significance: May explain signal amplification in cells expressing multiple receptors

• Ligand-independent activation:

  • Comparing phosphorylation patterns in ligand-dependent versus independent activation

  • Example system: HEK293 cells where EphBs cluster spontaneously and become activated in a ligand-independent manner

  • Application: Understanding pathological receptor activation in disease states

• Structure-function relationships:

  • Correlating structural information from crystallography with phosphorylation mechanisms

  • Approach: Introduce structure-guided mutations and monitor effects on phosphorylation

  • Insight from research: With the kinase domain structures of all four catalytically competent human EphB receptors now determined, opportunities emerge to understand differential activation mechanisms

These studies contribute to our fundamental understanding of receptor tyrosine kinase signaling beyond the EphB family .